Primary Record
Fostemsavir Tris
- In stock
- 4,449 g
- Purity
- 98.3 %
- CAS
- 864953-39-9
Compound Identifiers & Properties
- CAS
- 864953-39-9
- PubChem CID
- 46892186
- SMILES
- CC1=NN(C=N1)C2=NC=C(C3=C2N(C=C3C(=O)C(=O)N4CCN(CC4)C(=O)C5=CC=CC=C5)COP(=O)(O)O)OC.C(C(CO)(CO)N)O
- Canonical SMILES
- COc1cnc(-n2cnc(C)n2)c2c1c(C(=O)C(=O)N1CCN(C(=O)c3ccccc3)CC1)cn2COP(=O)(O)O.NC(CO)(CO)CO
Names & Synonyms
- Fostemsavir Tris
- Fostemsavir tromethamine
- Rukobia
- Fostemsavir
- 864953-39-9
- Fostemsavir trometamol
- BMS-663068 Tris
- Rukobia (TN)
- BMS 663068 (Tris)
- BMS-806 series
- RefChem:57108
- BMS-663068 (Tris)
- Fostemsavir tromethamine [USAN]
- UNII-2X513P36U0
- D00ZCT
- GSK3684934A
- BMS-663068 TROMETHAMINE
- BMS-663068
- GSK-3684934A
- HIV-1 entry inhibitors, BMS
- orb1309917
- 2X513P36U0
- CHEMBL3301598
- Fostemsavir tromethamine (USAN)
- SCHEMBL14659293
- SCHEMBL29376985
- BMS-216
- BMS-248
- BMS-663068-03
- BMS-705
- BMS-806
- BMS-853
- BMS663068
- C29H37N8O11P
- DTXSID201006863
- GLXC-10081
- HIV-1 attachment inhibitors, BMS
- BMS 663068
- BCP33672
- PJB95339
- 3038AH
- FOSTEMSAVIR TROMETHAMINE [MI]
- HY-15440B
- MFCD23098797
- C25H26N7O8P.C4H11NO3
- AKOS030526947
- BMS-378806
- BMS-626529
- CS-1060
- EBC-102101
- FOSTEMSAVIR TROMETAMOL [WHO-DD]
- BMS-488043 follow-on compounds, BMS
- DA-73539
- Fostemsavir Tris (BMS-663068 Tris)?
- FOSTEMSAVIR TROMETHAMINE [ORANGE BOOK]
- A15026
- D10708
- F84880
- W-5999
- A936470
- HIV-1 attachment inhibitors, Bristol-Myers Squibb
- Q27255740
- 2-Amino-2-(hydroxymethyl)propane-1,3-diol (3-(2-(4-benzoylpiperazin-1-yl)-2-oxoacetyl)-4-methoxy-7-(3-methyl-1H-1,2,4-triazol-1-yl)-1H-pyrrolo[2,3-c]pyridin-1-yl)methyl phosphate
- 1,2-Ethanedione, 1-(4-benzoyl-1-piperazinyl)-2-(4-methoxy-7-(3-methyl-1H-1,2,4-triazol-1-yl)-1-((phosphonooxy)methyl)-1H-pyrrolo(2,3-c)pyridin-3-yl)-, compd. with 2-amino-2-(hydroxymethyl)-1,3-propanediol (1:1)
- 2-amino-2-(hydroxymethyl)propane-1,3-diol;[3-[2-(4-benzoylpiperazin-1-yl)-2-oxoacetyl]-4-methoxy-7-(3-methyl-1,2,4-triazol-1-yl)pyrrolo[2,3-c]pyridin-1-yl]methyl dihydrogen phosphate
- (3-(2-(4-benzoylpiperazin-1-yl)-2-oxoacetyl)-4-methoxy-7-(3-methyl-1H-1,2,4-triazol-1-yl)-1H-pyrrolo(2,3-c)pyridin-1-yl)methyl (ester) and 1,3-dihydroxy-2-(hydroxymethyl)propan-2-aminium (salt) hydrogen phosphate
- Fostemsavir tromethamine;BMS-663068 Tris; BMS663068 Tris; BMS 663068 Tris
- (3-((4-Benzoyl-1-piperazinyl)(oxo)acetyl)-4-methoxy-7-(3-methyl-1H-1,2,4-triazol-1-yl)-1H-pyrrolo[2,3-c]pyridin-1-yl)methyl dihydrogen phosphate, 2-amino-2-(hydroxymethyl)-1,3-propanediol (1:1)
- {3-[(4-Benzoylpiperazin-1-yl)(oxo)acetyl]-4-methoxy-7-(3-methyl-1H-1,2,4-triazol-1-yl)-1H-pyrrolo[2,3-c]pyridin-1-yl}methyl dihydrogen phosphate--2-amino-2-(hydroxymethyl)propane-1,3-diol (1/1)
- {3-[2-(4-Benzoylpiperazin-1-yl)-2-oxoacetyl]-4-methoxy-7-(3-methyl-1H-1,2,4-triazol-1-yl)-1H-pyrrolo[2,3-c]pyridin-1-yl}methyl (ester) and 1,3-dihydroxy-2-(hydroxymethyl)propan-2-aminium (salt) hydrogen phosphate
- 1,2-Ethanedione, 1-(4-benzoyl-1-piperazinyl)-2-[4-methoxy-7-(3-methyl-1H-1,2,4-triazol-1-yl)-1-[(phosphonooxy)methyl]-1H-pyrrolo[2,3-C]pyridin-3-yl]-, compd with 2-amino-2-(hydroxymethyl)-1,3-propanediol (1:1)
- 2-amino-2-(hydroxymethyl)propane-1,3-diol;[3-[2-(4-benzoylpiperazin-1-yl)-2-oxo-acetyl]-4-methoxy-7-(3-methyl-1,2,4-triazol-1-yl)pyrrolo[2,3-c]pyridin-1-yl]methyl dihydrogen phosphate
- 357263-13-9
- 864953-29-7
- FTR